AKLI NASDAQ
Akili, Inc.
1W: -0.6%
1M: +2.7%
3M: +66.2%
1Y: -61.1%
$0.43
Last traded 2024-07-02 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$34.1M
52W Range0.1912-1.25
Volume236,452
Avg Volume2,146,798
Beta1.73
Dividend—
Analyst Ratings
Company Info
CEOMatthew Franklin
Employees68
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date2021-06-30
Websiteakiliinteractive.com
125 Broad Street
Boston, MA 02110
US
Boston, MA 02110
US
617-456-0597
About Akili, Inc.
Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| PureTech Health plc | U-Tender | 12,527,477 | $0.43 | 2024-07-02 |
| Palihapitiya Chamath | U-Tender | 1,900,000 | $0.43 | 2024-07-02 |
| Temasek Holdings (Pr | U-Tender | 10,336,425 | $0.43 | 2024-07-02 |
| Temasek Holdings (Pr | U-Tender | 1,172,697 | — | 2024-07-02 |
| Franklin Matthew | U-Tender | 7,657 | $0.43 | 2024-07-02 |